Cashing in on DNA: race on to unlock value in genetic data

  • World Premium
  • Friday, 03 Aug 2018

FILE PHOTO: A DNA double helix is seen in an undated artist's illustration released by the National Human Genome Research Institute to Reuters on May 15, 2012. REUTERS/National Human Genome Research Institute/Handout/File Photo

LONDON (Reuters) - How much is your DNA worth? As millions of people pay for home tests to check on ancestry or health risks, genetic data is becoming an increasingly valuable resource for drugmakers, triggering a race to create a DNA marketplace.

GlaxoSmithKline's decision to invest $300 million (230 million pounds) in 23andMe and forge an exclusive drug development deal with the Silicon Valley consumer genetics company crystallises the value locked up in genetic code.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In World

Several hit by gunshots at shopping mall in Copenhagen - Danish police Premium
China sweeps 13 diving golds at FINA World Championships Premium
Ukraine confirms withdrawal of its forces from Lysychansk Premium
1 injured in firing on polio eradication team in NW Pakistan Premium
China's digital economy more than quadruples in past decade Premium
Three Tunisian judges' unions suspend strike started a month ago - statement Premium
Australia will ban Russian gold imports, give Ukraine more armoured vehicles - PM Premium
Glacier collapses in Italian Alps, killing at least six Premium
Thousands wounded in unrest in Uzbekistan's Nukus - Uzbek news website Premium
Italy's Draghi to meet 5-Star chief with govt's future at risk Premium

Others Also Read